Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Micropapillary Serous Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Large-scale testing (Phase 3)Study completedNCT02101788
What this trial is testing

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Who this might be right for
Borderline Ovarian Serous TumorMicropapillary Serous CarcinomaOvarian Serous Adenocarcinoma+3 more
National Cancer Institute (NCI) 260
Testing effectiveness (Phase 2)Active Not RecruitingNCT03673124
What this trial is testing

Ribociclib and Letrozole Treatment in Ovarian Cancer

Who this might be right for
Low Grade Serous Carcinoma
Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Ended earlyNCT00231829
What this trial is testing

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Who this might be right for
Uterine Cancer
Mark H. Einstein 23
Large-scale testing (Phase 3)Study completedNCT01672892
What this trial is testing

Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer

Who this might be right for
Cervical CancerEndometrial CancerGastrointestinal Complications+4 more
Radiation Therapy Oncology Group 289
Large-scale testing (Phase 3)Study completedNCT03285802
What this trial is testing

Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

Who this might be right for
Uterine Cancer
Greater Baltimore Medical Center 1
Testing effectiveness (Phase 2)Study completedNCT00072176
What this trial is testing

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more
National Cancer Institute (NCI) 62
Not applicableStudy completedNCT01344837
What this trial is testing

Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

Who this might be right for
Endometrial Serous AdenocarcinomaStage I Uterine Corpus CancerStage II Uterine Corpus Cancer+2 more
Gynecologic Oncology Group 360
Testing effectiveness (Phase 2)Study completedNCT00515073
What this trial is testing

Papillary Serous Carcinoma of the Endometrium

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT00003560
What this trial is testing

Docetaxel Plus Carboplatin in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Endometrial CancerFallopian Tube CancerOvarian Cancer+1 more
Herbert Irving Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00022620
What this trial is testing

Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
European Organisation for Research and Treatment of Cancer - EORTC